{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:00Z","timestamp":1794047400683,"version":"4.8.0"},"reference-count":51,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Primary Epstein-Barr virus (EBV)-positive nodal T\/NK-cell lymphoma (PTCL-EBV) is a poorly understood disease which shows features resembling extranodal NK\/T-cell lymphoma (ENKTL) and is currently not recognized as a distinct entity but categorized as a variant of primary T-cell lymphoma not otherwise specified (PTCL-NOS). Herein, we analyzed copynumber aberrations (n=77) with a focus on global measures of genomic instability and homologous recombination deficiency and performed gene expression (n=84) and EBV miRNA expression (n=24) profiling as well as targeted mutational analysis (n=16) to further characterize PTCL-EBV in relation to ENKTL and PTCL-NOS. Multivariate analysis revealed that patients with PTCL-EBV had a significantly worse outcome compared to patients with PTCL-NOS (P=0.002) but not to those with ENKTL. Remarkably, PTCL-EBV exhibited significantly lower genomic instability and homologous recombination deficiency scores compared to ENKTL and PTCL-NOS. Gene set enrichment analysis revealed that many immune-related pathways, interferon \u03b1\/\u03b3 response, and IL6_JAK_STAT3 signaling were significantly upregulated in PTCLEBV and correlated with lower genomic instability scores. We also identified that NF\u03baB-associated genes, BIRC3, NFKB1 (P50) and CD27, and their proteins are upregulated in PTCL-EBV. Most PTCL-EBV demonstrated a type 2 EBV latency pattern and, strikingly, exhibited downregulated expression of most EBV miRNA compared to ENKTL and their target genes were also enriched in immune-related pathways. PTCL-EBV also showed frequent mutations of TET2, PIK3CD and STAT3, and are characterized by microsatellite stability. Overall, poor outcome, low genomic instability, upregulation of immune pathways and downregulation of EBV miRNA are distinctive features of PTCL-EBV. Our data support the concept that PTCL-EBV could be considered as a distinct entity, provide novel insights into the pathogenesis of the disease and offer potential new therapeutic targets for this tumor.<\/jats:p>","DOI":"10.3324\/haematol.2021.280003","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T02:35:12Z","timestamp":1642041312000},"page":"1864-1879","source":"Crossref","is-referenced-by-count":79,"title":["Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS"],"prefix":"10.3324","volume":"107","author":[{"given":"Cho Mar Myint","family":"Wai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"The","family":"Phyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Mun","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis Ching Yi","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoa-Nian","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Kuen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Hon Kim","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanus","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Sung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex K.H.","family":"Au-Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Yong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Thye","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon-Kiat","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Howe","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Mei","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"De Mel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand D.","family":"Jeyasekharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee-Joo","family":"Chng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zanardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Iannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tripodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siok-Bian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"38538","unstructured":"Ko YH, Chan JKC, Quintanilla-Martinez L. Virally associated T-cell and NK-cell neoplasms. 2017;565-598."},{"key":"38539","doi-asserted-by":"crossref","unstructured":"Kato S, Asano N, Miyata-Takata T. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases. Am J Surg Pathol. 2015; 39(4):462-471.","DOI":"10.1097\/PAS.0000000000000323"},{"key":"38540","doi-asserted-by":"crossref","unstructured":"Kato S, Takahashi E, Asano N. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases. Histopathology. 2012; 61(2):186-199.","DOI":"10.1111\/j.1365-2559.2012.04199.x"},{"key":"38541","doi-asserted-by":"crossref","unstructured":"Ng SB, Chung TH, Kato S. Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes. Haematologica. 2018; 103(2):278-287.","DOI":"10.3324\/haematol.2017.180430"},{"key":"38542","unstructured":"Pileri SA, Weisenburger DD, Sng I. Peripheral T-cell lymphoma, NOS. International Agency for Research on Cancer; Lyon. 2017;403-407."},{"key":"38543","doi-asserted-by":"crossref","unstructured":"Pikor L, Thu K, Vucic E, Lam W. The detection and implication of genome instability in cancer. Cancer Metastasis Rev. 2013; 32(3-4):341-352.","DOI":"10.1007\/s10555-013-9429-5"},{"key":"38544","doi-asserted-by":"crossref","unstructured":"Ahmad SS, Ahmed K, Venkitaraman AR. Science in focus: genomic instability and its implications for clinical cancer care. Clin Oncol. 2018; 30(12):751-755.","DOI":"10.1016\/j.clon.2018.09.001"},{"key":"38545","doi-asserted-by":"crossref","unstructured":"Oon ML, Lim JQ, Lee B. T-cell lymphoma clonality by copy number variation analysis of T-cell receptor genes. Cancers (Basel). 2021; 13(2):340.","DOI":"10.3390\/cancers13020340"},{"key":"38546","doi-asserted-by":"crossref","unstructured":"Lee CS, Bhaduri A, Mah A. Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma. Nat Genet. 2014; 46(10):1060-1062.","DOI":"10.1038\/ng.3091"},{"key":"38547","doi-asserted-by":"crossref","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011; 12(4):R41.","DOI":"10.1186\/gb-2011-12-4-r41"},{"key":"38548","doi-asserted-by":"crossref","unstructured":"Sinha S, Mitchell KA, Zingone A. Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans. Nat Cancer. 2020; 1(1):112-121.","DOI":"10.1038\/s43018-019-0009-7"},{"key":"38549","doi-asserted-by":"crossref","unstructured":"Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn. 2003; 5(2):73-81.","DOI":"10.1016\/S1525-1578(10)60455-2"},{"key":"38550","doi-asserted-by":"crossref","unstructured":"Kato S, Yamashita D, Nakamura S. Nodal EBV+ cytotoxic T-cell lymphoma: a literature review based on the 2017 WHO classification. J Clin Exp Hematop. 2020; 60(2):30-36.","DOI":"10.3960\/jslrt.20001"},{"key":"38551","doi-asserted-by":"crossref","unstructured":"Ha SY, Sung J, Ju H. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study. Pathol Res Pract. 2013; 209(7):448-454.","DOI":"10.1016\/j.prp.2013.04.013"},{"key":"38552","doi-asserted-by":"crossref","unstructured":"Takahashi E, Asano N, Li C. Nodal T\/NK-cell lymphoma of nasal type: a clinicopathological study of six cases. Histopathology. 2008; 52(5):585-596.","DOI":"10.1111\/j.1365-2559.2008.02997.x"},{"key":"38553","doi-asserted-by":"crossref","unstructured":"Gong Q, Wang C, Zhang W. Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data. Sci Rep. 2017; 7(1):11301.","DOI":"10.1038\/s41598-017-11310-0"},{"key":"38554","doi-asserted-by":"crossref","unstructured":"Li Y, Roberts ND, Wala JA. Patterns of somatic structural variation in human cancer genomes. Nature. 2020; 578(7793):112-121.","DOI":"10.1038\/s41586-019-1913-9"},{"key":"38555","doi-asserted-by":"crossref","unstructured":"Pitt JJ, Riester M, Zheng Y. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nat Commun. 2018; 9(1):4181.","DOI":"10.1038\/s41467-018-06616-0"},{"key":"38556","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Gable AL, Lyon D. STRING v11: proteinprotein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019; 47(D1):D607-D613.","DOI":"10.1093\/nar\/gky1131"},{"key":"38557","doi-asserted-by":"crossref","unstructured":"Song TL, Nairism\u00e4gi M-L, Laurensia Y. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma. Blood. 2018; 132(11):1146-1158.","DOI":"10.1182\/blood-2018-01-829424"},{"key":"38558","doi-asserted-by":"crossref","unstructured":"Garcia-Diaz A, Shin DS, Moreno BH. Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep. 2017; 19(6):1189-1201.","DOI":"10.1016\/j.celrep.2017.04.031"},{"key":"38559","doi-asserted-by":"crossref","unstructured":"Asgarova A, Asgarov K, Godet Y. PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma. Oncoimmunology. 2018; 7(5):e1423170.","DOI":"10.1080\/2162402X.2017.1423170"},{"key":"38560","doi-asserted-by":"crossref","unstructured":"Shklovskaya E, Rizos H. Spatial and temporal changes in PD-L1 expression in cancer: the role of genetic drivers, tumor microenvironment and resistance to therapy. Int J Mol Sci. 2020; 21(19):7139.","DOI":"10.3390\/ijms21197139"},{"key":"38561","doi-asserted-by":"crossref","unstructured":"Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012; 149(3):515-524.","DOI":"10.1016\/j.cell.2012.04.005"},{"key":"38562","doi-asserted-by":"crossref","unstructured":"Ferrone CK, Blydt-Hansen M, Rauh MJ. Age-associated TET2 mutations: common drivers of myeloid dysfunction, cancer and cardiovascular disease. Int J Mol Sci. 2020; 21(2):626.","DOI":"10.3390\/ijms21020626"},{"key":"38563","doi-asserted-by":"crossref","unstructured":"Riviere P, Goodman AM, Okamura R. High tumor mutational burden correlates with longer survival in immunotherapy-na\u00efve patients with diverse cancers. Mol Cancer Ther. 2020; 19(10):2139-2145.","DOI":"10.1158\/1535-7163.MCT-20-0161"},{"key":"38564","doi-asserted-by":"crossref","unstructured":"Liang WS, Vergilio J-A, Salhia B. Comprehensive genomic profiling of Hodgkin lymphoma reveals recurrently mutated genes and Increased mutation burden. Oncologist. 2019; 24(2):219-228.","DOI":"10.1634\/theoncologist.2018-0058"},{"key":"38565","doi-asserted-by":"crossref","unstructured":"Kamranvar SA, Gruhne B, Szeles A, Masucci MG. Epstein-Barr virus promotes genomic instability in Burkitt\u2019s lymphoma. Oncogene. 2007; 26(35):5115-5123.","DOI":"10.1038\/sj.onc.1210324"},{"key":"38566","doi-asserted-by":"crossref","unstructured":"Nagy M, Bal\u00e1zs M, Ad\u00e1m Z. Genetic instability is associated with histological transformation of follicle center lymphoma. Leukemia. 2000; 14(12):2142-2148.","DOI":"10.1038\/sj.leu.2401978"},{"key":"38567","doi-asserted-by":"crossref","unstructured":"Hieronymus H, Murali R, Tin A. Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. Elife. 2018; 7:e37294.","DOI":"10.7554\/eLife.37294"},{"key":"38568","doi-asserted-by":"crossref","unstructured":"Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018; 18(5):309-324.","DOI":"10.1038\/nri.2017.142"},{"key":"38569","doi-asserted-by":"crossref","unstructured":"Yeo CQX, Alexander I, Lin Z. p53 maintains genomic stability by preventing interference between transcription and replication. Cell Rep. 2016; 15(1):132-146.","DOI":"10.1016\/j.celrep.2016.03.011"},{"key":"38570","doi-asserted-by":"crossref","unstructured":"Ramachandiran S, Adon A, Guo X. Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-\u03baB pathway. Int J Cancer. 2015; 136(10):2341-2351.","DOI":"10.1002\/ijc.29301"},{"key":"38571","doi-asserted-by":"crossref","unstructured":"Crawley CD, Kang S, Bernal GM. S-phase-dependent p50\/NF-B1 phosphorylation in response to ATR and replication stress acts to maintain genomic stability. Cell Cycle. 2015; 14(4):566-576.","DOI":"10.4161\/15384101.2014.991166"},{"key":"38572","doi-asserted-by":"crossref","unstructured":"Wang J, Jacob NK, Ladner KJ. RelA\/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair. EMBO Rep. 2009; 10(11):1272-1278.","DOI":"10.1038\/embor.2009.197"},{"key":"38573","doi-asserted-by":"crossref","unstructured":"Fennell KA, Bell CC, Dawson MA. Epigenetic therapies in acute myeloid leukemia: where to from here?. Blood. 2019; 134(22):1891-1901.","DOI":"10.1182\/blood.2019003262"},{"key":"38574","doi-asserted-by":"crossref","unstructured":"Betzler AC, Theodoraki M-N, Schuler PJ. NF-\u03baB and Its role in checkpoint control. Int J Mol Sci. 2020; 21(11):3949.","DOI":"10.3390\/ijms21113949"},{"key":"38575","doi-asserted-by":"crossref","unstructured":"Xia Y, Shen S, Verma IM. NF-\u03baB, an active player in human cancers. Cancer Immunol Res. 2014; 2(9):823-830.","DOI":"10.1158\/2326-6066.CIR-14-0112"},{"key":"38576","doi-asserted-by":"crossref","unstructured":"Lu C, Klement JD, Smith AD. p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy. J Immunother Cancer. 2020; 8(2):e001365.","DOI":"10.1136\/jitc-2020-001365"},{"key":"38577","doi-asserted-by":"crossref","unstructured":"Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005; 17(3):275-281.","DOI":"10.1016\/j.coi.2005.04.004"},{"key":"38578","doi-asserted-by":"crossref","unstructured":"Riether C, Sch\u00fcrch C, Ochsenbein AF. Modulating CD27 signaling to treat cancer. Oncoimmunology. 2012; 1(9):1604-1606.","DOI":"10.4161\/onci.21425"},{"key":"38579","doi-asserted-by":"crossref","unstructured":"\u017didovec Lepej S, Matuli\u0107 M, Gr\u0161kovi\u0107 P, Pavlica M, Radmani\u0107 L, Kora\u0107 P. miRNAs: EBV mechanism for escaping host\u2019s immune response and supporting tumorigenesis. Pathogens. 2020; 9(5):353.","DOI":"10.3390\/pathogens9050353"},{"key":"38580","doi-asserted-by":"crossref","unstructured":"Wang L, Qin W, Huo Y-J. Advances in targeted therapy for malignant lymphoma. Signal Transduct Target Ther. 2020; 5(1):15.","DOI":"10.1038\/s41392-020-0113-2"},{"key":"38581","doi-asserted-by":"crossref","unstructured":"Godwin P, Baird AM, Heavey S, Barr MP, O\u2019Byrne KJ, Gately K. Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Front Oncol. 2013; 3:120.","DOI":"10.3389\/fonc.2013.00120"},{"key":"38582","doi-asserted-by":"crossref","unstructured":"Spaccarelli N, Rook AH. The use of interferons in the treatment of cutaneous T-cell lymphoma. Dermatol Clin. 2015; 33(4):731-745.","DOI":"10.1016\/j.det.2015.05.008"},{"key":"38583","doi-asserted-by":"crossref","unstructured":"Chihara N, Madi A, Kondo T. Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature. 2018; 558(7710):454-459.","DOI":"10.1038\/s41586-018-0206-z"},{"key":"38584","doi-asserted-by":"crossref","unstructured":"Green MR, Monti S, Rodig SJ. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood. 2010; 116(17):3268-3277.","DOI":"10.1182\/blood-2010-05-282780"},{"key":"38585","doi-asserted-by":"crossref","unstructured":"Lim JQ, Huang D, Tang T. Whole-genome sequencing identifies responders to pembrolizumab in relapse\/refractory natural-killer\/T cell lymphoma. Leukemia. 2020; 34(12):3413-3419.","DOI":"10.1038\/s41375-020-1000-0"},{"key":"38586","doi-asserted-by":"crossref","unstructured":"Xu ZG, Iwatsuki K, Oyama N. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer\/T-cell lymphomas. Br J Cancer. 2001; 84(7):920-925.","DOI":"10.1054\/bjoc.2000.1687"},{"key":"38587","doi-asserted-by":"crossref","unstructured":"Chiang AK, Tao Q, Srivastava G, Ho FC. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin\u2019s disease. Int J Cancer. 1996; 68(3):285-290.","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y"},{"key":"38588","doi-asserted-by":"crossref","unstructured":"Yamashita D, Shimada K, Takata K. Reappraisal of nodal Epstein-Barr virus-negative cytotoxic T-cell lymphoma: Identification of indolent CD5 diseases. Cancer Sci. 2018; 109(8):2599-2610.","DOI":"10.1111\/cas.13652"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.280003\/74056","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.280003\/74685","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10505\/74056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:00:53Z","timestamp":1794045653000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.280003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.280003","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,13]]}}}